SHILPA MEDICARE LTD. - Important Milestone For The Biologics Business Of Shilpa Medicare Limited ('SML')Shilpa Biologics Pvt Ltd ('SBPL') Receives First International Market Approval For Adalimumab 40 Mg/0.4 Ml Solution For Injection In MOROCCO
23 Jul 2024
Shilpa Biologicals private limited a wholly owned subsidiary of the Company has registration approval for Adalimumab from morocco, MOH. This is the first biosimilar approval from any international market for high concentration adalimumab developed by SBPL.
Source:
BSE India